GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -50.0% | 36 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 36 | -39.0% | 0.00% | – |
| Q3 2020 | $3,000 | -99.2% | 59 | -99.0% | 0.00% | -100.0% |
| Q2 2020 | $362,000 | +22.3% | 5,735 | -0.9% | 0.02% | +5.3% |
| Q1 2020 | $296,000 | -35.7% | 5,787 | +0.0% | 0.02% | -20.8% |
| Q4 2019 | $460,000 | +43.3% | 5,785 | -5.4% | 0.02% | +20.0% |
| Q3 2019 | $321,000 | 0.0% | 6,112 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $321,000 | +0.9% | 6,112 | +1.7% | 0.02% | -9.1% |
| Q1 2019 | $318,000 | – | 6,007 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |